Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.
Prenosis has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Prenosis's investors include National Science Foundation, UC Investments, Global Health Investment Corporation, LabCorp Venture Fund, PACE Healthcare Capital.
Prenosis is headquartered in Chicago, United States.
Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.
Prenosis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prenosis — Funding & Investors." VCBacked, January 29, 2026, https://www.vcbacked.co/company/prenosis. Accessed September 13, 2026.
VCBacked. (2026). Prenosis — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/prenosis
{{cite web |title=Prenosis — Funding & Investors |url=https://www.vcbacked.co/company/prenosis |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated